<p>Intuitive Surgical, Inc.（纳斯达克股票代码：ISRG - 获取免费报告）在 8 月份看到了空头头寸的显著增加。截至 8 月 15 日，空头头寸总计为 3,740,000 股，比 7 月 31 日的 3,390,000 股增加了 10.3%。根据平均每日交易量为 1,520,000 股，目前的偿付天数比率为 2.5 天。</p>
<p>获取 <strong>直觉外科</strong> 警报：</p>
<h2>直觉外科内部交易</h2>
<ul>
<li>3 家未来 10 年值得拥有的最佳成长股</li>
</ul>
<p>在其他直觉外科的消息中，执行副总裁 Robert Desantis 在 6 月 10 日星期一进行了一笔交易，卖出了 239 股股票。股票以每股平均价格 416.60 美元出售，总价值为 99,567.40 美元。交易完成后，这位执行副总裁现在直接持有公司的 5,506 股股票，价值 2,293,799.60 美元。该交易已在提交给美国证券交易委员会（SEC）的文件中披露，可在此链接找到。另外，高级副总裁 Henry L. Charlton 在 8 月 23 日星期五进行了一笔交易，卖出了 40,243 股股票。股票以每股平均价格 486.84 美元出售，总价值为 19,591,902.12 美元。交易完成后，这位高级副总裁现在直接持有公司的 3,001 股股票，价值 1,461,006.84 美元。该交易已在提交给 SEC 的文件中披露，可在此链接找到。此外，执行副总裁 Robert Desantis 在 6 月 10 日星期一进行了一笔交易，卖出了 239 股股票。股票以每股平均价格 416.60 美元出售，总价值为 99,567.40 美元。交易完成后，这位执行副总裁现在持有公司的 5,506 股股票，价值 2,293,799.60 美元。关于此次交易的披露可在此处找到。过去 90 天，内部人士共出售了价值 26,281,657 美元的 55,552 股公司股票。公司股份的 0.90% 归内部人士所有。</p>
<h2>机构投资者对直觉外科的看法</h2>
<p>最近，机构投资者调整了他们对该公司的持股。Advisors Asset Management Inc.在第一季度将其在直觉外科的持股增加了 18.1%。Advisors Asset Management Inc.现在拥有 7,380 股医疗设备提供商的股票，价值 2,945,000 美元，比上一季度增加了 1,129 股。Provence Wealth Management Group 在第 4 季度以 276,000 美元的价格获得了直觉外科的新头寸。俄亥俄州公共雇员退休系统在第 4 季度将其在直觉外科的持股增加了 5.4%。俄亥俄州公共雇员退休系统现在拥有 191,283 股医疗设备提供商的股票，价值 64,531,000 美元，比上一季度增加了 9,869 股。HCR Wealth Advisors 在第 4 季度将其在直觉外科的持股增加了 26.3%。HCR Wealth Advisors 现在拥有 1,042 股医疗设备提供商的股票，价值 352,000 美元，比上一季度增加了 217 股。最后，Checchi Capital Advisers LLC 在第 4 季度将其在直觉外科的持股增加了 2.5%。Checchi Capital Advisers LLC 现在拥有 2,875 股医疗设备提供商的股票，价值 970,000 美元，比上一季度增加了 70 股。83.64% 的股份由机构投资者和对冲基金持有。</p>
<h2>直觉外科股票表现</h2>
<ul>
<li>违背市场：3 家市值巨大的股票飙升至新高</li>
</ul>
<p>直觉外科股票周五开盘价为 492.63 美元。直觉外科股票一年最低价为 254.85 美元，一年最高价为 493.97 美元。该公司的市值为 1747.4 亿美元，市盈率为 88.92，PEG 比率为 4.97，贝塔系数为 1.39。公司的 50 天移动平均价格为 454.69 美元，200 天移动平均价格为 414.46 美元。</p>
<p>直觉外科（纳斯达克股票代码：ISRG - 获取免费报告）于 7 月 18 日星期四发布了其收益结果。这家医疗设备提供商报告称，该季度每股收益（EPS）为 1.78 美元，超过了 1.54 美元的共识预期 0.24 美元。该公司在本季度实现了 20.1 亿美元的收入，而分析师预期为 19.7 亿美元。直觉外科的净资产收益率为 13.04%，净利润率为 27.65%。公司本季度的营收同比增长了 14.5%。去年同期，该公司每股收益为 1.18 美元。分析师平均预计，直觉外科本财年将实现 5.22 美元的每股收益。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>PROCEPT BioRobotics 是否是外科机器人领域的下一个大事件？</li>
</ul>
<p>一些研究分析师最近对 ISRG 股票发表了意见。BTIG Research 将直觉外科的目标股价从 469.00 美元上调至 494.00 美元，并在周三的报告中给予该公司 “买入” 评级。Stifel Nicolaus 将直觉外科的目标股价从 430.00 美元上调至 475.00 美元，并在 7 月 19 日星期五的报告中给予该公司 “买入” 评级。花旗集团将直觉外科的目标股价从 512.00 美元上调至 560.00 美元，并在 8 月 22 日星期四的报告中给予该公司 “买入” 评级。Piper Sandler 将直觉外科的目标股价从 490.00 美元上调至 495.00 美元，并在 7 月 19 日星期五的报告中给予该公司 “超配” 评级。最后，Redburn Atlantic 将直觉外科的评级从 “中性” 上调至 “买入”，并将股票的目标价格从 380.00 美元上调至 510.00 美元。六家股票研究分析公司对该股票给予持有评级，十五家给予买入评级。根据 MarketBeat 的数据，该公司的平均评级为 “中等买入”，平均目标股价为 446.45 美元。</p>
<p><strong>查看我们关于直觉外科的最新股票报告</strong></p>
<h2>关于直觉外科（获取免费报告）</h2>
<p>直觉外科公司开发、制造和销售产品，使医生和医疗服务提供者能够提高美国和国际范围内微创护理的质量和获取途径。该公司提供 da Vinci 外科系统，可通过微创手术方法进行复杂手术；Ion 内腔系统扩展了其商业产品范围，不仅可用于手术，还可进行诊断程序，实现肺部微创活检。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们比直觉外科更喜欢的股票</li>
<li>投资汽车股</li>
<li>柏肯斯托克的突然下滑—为什么它可能是你下一个大赢家</li>
<li>五美元以下的最佳股票</li>
<li>MarketBeat 周回顾 – 8/26 - 8/30</li>
<li>为什么这些公司被视为蓝筹股？</li>
<li>维娃股价因 Q2 业绩大涨而飙升—别错过</li>
</ul>
<p><em>这则即时新闻警报是由叙事科技和来自 MarketBeat 的财务数据生成，旨在为读者提供最快速和准确的报道。本故事在发布前已经由 MarketBeat 的编辑团队进行了审查。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<p>→ 这个能拯救你退休的 15 美元&#34;内幕秘密&#34;（来自市场幕后）(广告)</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NDUx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NDUx"/></p>
<h2>现在是否值得投资 1,000 美元购买直觉外科股票？</h2>
<p>在考虑投资直觉外科之前，您应该听听这个。</p>
<p>MarketBeat 追踪华尔街评级最高、表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已经确定了五只顶级分析师悄悄告诉他们的客户现在购买的股票清单... 而直觉外科并不在其中。</p>
<p>尽管直觉外科目前在分析师中有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

直觉外科

<p>Intuitive Surgical, Inc.（纳斯达克股票代码：ISRG）在 8 月份的空头头寸增加了 10.3%，达到了 3,740,000 股，截至 8 月 15 日。这一增长表明，根据平均交易量为 1,520,000 股，股票的日平均交易量覆盖率为 2.5 天。此外，内部人士在过去三个月内出售了价值 4,281,657 美元的 55,552 股股票，而机构投资者持有该公司 83.64% 的股份。Intuitive Surgical 报告的第二季度每股收益为 1.78 美元，超过了预期，营收同比增长了 14.5%。该公司的股价在过去一年中介于 85 美元和 97 美元之间</p>

<p>Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) saw a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 3,740,000 shares, an increase of 10.3% from the July 31st total of 3,390,000 shares. Based on an average daily trading volume, of 1,520,000 shares, the days-to-cover ratio is presently 2.5 days.</p>
<div class="lb-trans"><p>Intuitive Surgical, Inc.（纳斯达克股票代码：ISRG - 获取免费报告）在 8 月份看到了空头头寸的显著增加。截至 8 月 15 日，空头头寸总计为 3,740,000 股，比 7 月 31 日的 3,390,000 股增加了 10.3%。根据平均每日交易量为 1,520,000 股，目前的偿付天数比率为 2.5 天。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>直觉外科</strong> 警报：</p>
</div><h2>Insider Buying and Selling at Intuitive Surgical</h2>
<ul>
<li>3 Best Growth Stocks to Own for the Next 10 Years</li>
</ul>
<div class="lb-trans"><h2>直觉外科内部交易</h2>
<ul>
<li>3 家未来 10 年值得拥有的最佳成长股</li>
</ul>
</div><p>In other Intuitive Surgical news, EVP Robert Desantis sold 239 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $416.60, for a total value of $99,567.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,293,799.60. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Robert Desantis sold 239 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company's stock, valued at $2,293,799.60. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 55,552 shares of company stock worth $26,281,657. 0.90% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他直觉外科的消息中，执行副总裁 Robert Desantis 在 6 月 10 日星期一进行了一笔交易，卖出了 239 股股票。股票以每股平均价格 416.60 美元出售，总价值为 99,567.40 美元。交易完成后，这位执行副总裁现在直接持有公司的 5,506 股股票，价值 2,293,799.60 美元。该交易已在提交给美国证券交易委员会（SEC）的文件中披露，可在此链接找到。另外，高级副总裁 Henry L. Charlton 在 8 月 23 日星期五进行了一笔交易，卖出了 40,243 股股票。股票以每股平均价格 486.84 美元出售，总价值为 19,591,902.12 美元。交易完成后，这位高级副总裁现在直接持有公司的 3,001 股股票，价值 1,461,006.84 美元。该交易已在提交给 SEC 的文件中披露，可在此链接找到。此外，执行副总裁 Robert Desantis 在 6 月 10 日星期一进行了一笔交易，卖出了 239 股股票。股票以每股平均价格 416.60 美元出售，总价值为 99,567.40 美元。交易完成后，这位执行副总裁现在持有公司的 5,506 股股票，价值 2,293,799.60 美元。关于此次交易的披露可在此处找到。过去 90 天，内部人士共出售了价值 26,281,657 美元的 55,552 股公司股票。公司股份的 0.90% 归内部人士所有。</p>
</div><h2>Institutional Investors Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>机构投资者对直觉外科的看法</h2>
<p>最近，机构投资者调整了他们对该公司的持股。Advisors Asset Management Inc.在第一季度将其在直觉外科的持股增加了 18.1%。Advisors Asset Management Inc.现在拥有 7,380 股医疗设备提供商的股票，价值 2,945,000 美元，比上一季度增加了 1,129 股。Provence Wealth Management Group 在第 4 季度以 276,000 美元的价格获得了直觉外科的新头寸。俄亥俄州公共雇员退休系统在第 4 季度将其在直觉外科的持股增加了 5.4%。俄亥俄州公共雇员退休系统现在拥有 191,283 股医疗设备提供商的股票，价值 64,531,000 美元，比上一季度增加了 9,869 股。HCR Wealth Advisors 在第 4 季度将其在直觉外科的持股增加了 26.3%。HCR Wealth Advisors 现在拥有 1,042 股医疗设备提供商的股票，价值 352,000 美元，比上一季度增加了 217 股。最后，Checchi Capital Advisers LLC 在第 4 季度将其在直觉外科的持股增加了 2.5%。Checchi Capital Advisers LLC 现在拥有 2,875 股医疗设备提供商的股票，价值 970,000 美元，比上一季度增加了 70 股。83.64% 的股份由机构投资者和对冲基金持有。</p>
</div><p>Institutional investors have recently modified their holdings of the company. Advisors Asset Management Inc. grew its stake in shares of Intuitive Surgical by 18.1% in the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider's stock valued at $2,945,000 after buying an additional 1,129 shares in the last quarter. Provence Wealth Management Group acquired a new position in Intuitive Surgical during the 4th quarter worth $276,000. Public Employees Retirement System of Ohio grew its stake in Intuitive Surgical by 5.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider's stock worth $64,531,000 after purchasing an additional 9,869 shares in the last quarter. HCR Wealth Advisors lifted its holdings in Intuitive Surgical by 26.3% during the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider's stock worth $352,000 after buying an additional 217 shares during the last quarter. Finally, Checchi Capital Advisers LLC lifted its holdings in Intuitive Surgical by 2.5% during the 4th quarter. Checchi Capital Advisers LLC now owns 2,875 shares of the medical equipment provider's stock worth $970,000 after buying an additional 70 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.</p>
<h2>Intuitive Surgical Stock Performance</h2>
<ul>
<li>Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs</li>
</ul>
<div class="lb-trans"><h2>直觉外科股票表现</h2>
<ul>
<li>违背市场：3 家市值巨大的股票飙升至新高</li>
</ul>
</div><p>Shares of Intuitive Surgical stock opened at $492.63 on Friday. Intuitive Surgical has a one year low of $254.85 and a one year high of $493.97. The company has a market cap of $174.74 billion, a price-to-earnings ratio of 88.92, a PEG ratio of 4.97 and a beta of 1.39. The business's 50 day moving average price is $454.69 and its 200 day moving average price is $414.46.</p>
<div class="lb-trans"><p>直觉外科股票周五开盘价为 492.63 美元。直觉外科股票一年最低价为 254.85 美元，一年最高价为 493.97 美元。该公司的市值为 1747.4 亿美元，市盈率为 88.92，PEG 比率为 4.97，贝塔系数为 1.39。公司的 50 天移动平均价格为 454.69 美元，200 天移动平均价格为 414.46 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to analysts' expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm's quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.18 earnings per share. On average, analysts predict that Intuitive Surgical will post 5.22 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>直觉外科（纳斯达克股票代码：ISRG - 获取免费报告）于 7 月 18 日星期四发布了其收益结果。这家医疗设备提供商报告称，该季度每股收益（EPS）为 1.78 美元，超过了 1.54 美元的共识预期 0.24 美元。该公司在本季度实现了 20.1 亿美元的收入，而分析师预期为 19.7 亿美元。直觉外科的净资产收益率为 13.04%，净利润率为 27.65%。公司本季度的营收同比增长了 14.5%。去年同期，该公司每股收益为 1.18 美元。分析师平均预计，直觉外科本财年将实现 5.22 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<ul>
<li>Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?</li>
</ul>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
<ul>
<li>PROCEPT BioRobotics 是否是外科机器人领域的下一个大事件？</li>
</ul>
</div><p>A number of research analysts have recently weighed in on ISRG shares. BTIG Research increased their price objective on Intuitive Surgical from $469.00 to $494.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday. Stifel Nicolaus increased their price objective on Intuitive Surgical from $430.00 to $475.00 and gave the company a &#34;buy&#34; rating in a report on Friday, July 19th. Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, August 22nd. Piper Sandler increased their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, July 19th. Finally, Redburn Atlantic raised Intuitive Surgical from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their target price for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of &#34;Moderate Buy&#34; and an average price target of $446.45.</p>
<div class="lb-trans"><p>一些研究分析师最近对 ISRG 股票发表了意见。BTIG Research 将直觉外科的目标股价从 469.00 美元上调至 494.00 美元，并在周三的报告中给予该公司 “买入” 评级。Stifel Nicolaus 将直觉外科的目标股价从 430.00 美元上调至 475.00 美元，并在 7 月 19 日星期五的报告中给予该公司 “买入” 评级。花旗集团将直觉外科的目标股价从 512.00 美元上调至 560.00 美元，并在 8 月 22 日星期四的报告中给予该公司 “买入” 评级。Piper Sandler 将直觉外科的目标股价从 490.00 美元上调至 495.00 美元，并在 7 月 19 日星期五的报告中给予该公司 “超配” 评级。最后，Redburn Atlantic 将直觉外科的评级从 “中性” 上调至 “买入”，并将股票的目标价格从 380.00 美元上调至 510.00 美元。六家股票研究分析公司对该股票给予持有评级，十五家给予买入评级。根据 MarketBeat 的数据，该公司的平均评级为 “中等买入”，平均目标股价为 446.45 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我们关于直觉外科的最新股票报告</strong></p>
</div><h2>About Intuitive Surgical (Get Free Report)</h2>
<div class="lb-trans"><h2>关于直觉外科（获取免费报告）</h2>
</div><p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p>
<div class="lb-trans"><p>直觉外科公司开发、制造和销售产品，使医生和医疗服务提供者能够提高美国和国际范围内微创护理的质量和获取途径。该公司提供 da Vinci 外科系统，可通过微创手术方法进行复杂手术；Ion 内腔系统扩展了其商业产品范围，不仅可用于手术，还可进行诊断程序，实现肺部微创活检。</p>
</div><h2>Recommended Stories</h2>
<ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Investing In Automotive Stocks</li>
<li>Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win</li>
<li>Best Stocks Under $5.00</li>
<li>MarketBeat Week in Review – 8/26 - 8/30</li>
<li>Why Are These Companies Considered Blue Chips?</li>
<li>Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out</li>
</ul>
<div class="lb-trans"><h2>推荐故事</h2>
<ul>
<li>五只我们比直觉外科更喜欢的股票</li>
<li>投资汽车股</li>
<li>柏肯斯托克的突然下滑—为什么它可能是你下一个大赢家</li>
<li>五美元以下的最佳股票</li>
<li>MarketBeat 周回顾 – 8/26 - 8/30</li>
<li>为什么这些公司被视为蓝筹股？</li>
<li>维娃股价因 Q2 业绩大涨而飙升—别错过</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>这则即时新闻警报是由叙事科技和来自 MarketBeat 的财务数据生成，旨在为读者提供最快速和准确的报道。本故事在发布前已经由 MarketBeat 的编辑团队进行了审查。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><p>→ The $15 &#34;Insider Secret&#34; That Could Save Your Retirement (From Behind the Markets)(Ad)</p>
<div class="lb-trans"><p>→ 这个能拯救你退休的 15 美元&#34;内幕秘密&#34;（来自市场幕后）(广告)</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NDUx" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9451&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Intuitive Surgical right now?</h2>
<div class="lb-trans"><h2>现在是否值得投资 1,000 美元购买直觉外科股票？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资直觉外科之前，您应该听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追踪华尔街评级最高、表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已经确定了五只顶级分析师悄悄告诉他们的客户现在购买的股票清单... 而直觉外科并不在其中。</p>
</div><p>While Intuitive Surgical currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管直觉外科目前在分析师中有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

直觉外科公司（纳斯达克代码：ISRG）空头头寸最新情况